Brainsway (BWAY) Interest & Investment Income (2023 - 2026)
Brainsway (BWAY) posted quarterly Interest & Investment Income of $724000.0 for Q1 2026, down 43.17% year-on-year from $1.3 million in Q1 2025, and down 31.44% on a QoQ basis from $1.1 million in Q4 2025.
Brainsway (BWAY) Interest & Investment Income (2023 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Interest & Investment Income for 4 consecutive years, with $724000.0 the latest figure, recorded in Q1 2026.
- Quarterly Interest & Investment Income fell 43.17% year-over-year to $724000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (up 22.25% YoY) and the FY2025 annual result came in at $5.6 million, up 56.14% from the prior year.
- Interest & Investment Income declined to $724000.0 in Q1 2026 per BWAY's latest filing, from $1.1 million in the prior quarter.
- Over the last five years, Interest & Investment Income for BWAY reached as high as $2.3 million in Q2 2025 and fell as low as $175000.0 in Q3 2023.
- A 4-year average of $978307.7 and a median of $830000.0 in 2024 frame the typical range for Interest & Investment Income.
- The largest YoY upside for Interest & Investment Income was 374.29% in 2024 against a maximum downside of 56.6% in 2024.
- Year by year, Interest & Investment Income stood at $588000.0 in 2023, then surged by 178.74% to $1.6 million in 2024, then slumped by 35.57% to $1.1 million in 2025, then sank by 31.44% to $724000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $724000.0, $1.1 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Brainsway | 598.04 Mn | 538.27 Mn | 11.68 Mn | 724,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 724,000.00 |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 2.30 Mn |
| Mar 31, 2025 | 1.27 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Sep 30, 2024 | 830,000.00 |
| Jun 30, 2024 | 518,000.00 |
| Mar 31, 2024 | 618,000.00 |
| Dec 31, 2023 | 588,000.00 |
| Sep 30, 2023 | 175,000.00 |
| Jun 30, 2023 | 443,000.00 |
| Mar 31, 2023 | 1.42 Mn |